NCT00668564 Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism Status TERMINATED Phase PHASE2
NCT00667927 Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission Status COMPLETED Phase PHASE1
NCT00667329 Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab Status COMPLETED Phase PHASE1
NCT00666484 Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT00665990 Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia Status COMPLETED Phase PHASE1
NCT00665457 Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery Status TERMINATED Phase PHASE2
NCT00662233 Combination Chemotherapy in Treating Patients With Sarcoma Status COMPLETED Phase EARLY_PHASE1
NCT00656123 Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00653068 Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System Status COMPLETED Phase PHASE3
NCT00652899 Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer Status TERMINATED Phase PHASE2
NCT00652691 Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT00651755 Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients Status COMPLETED Phase NA
NCT00641381 Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma Status COMPLETED Phase PHASE1
NCT00641095 Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma Status COMPLETED Phase PHASE2/PHASE3
NCT00637832 Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE2
NCT00636909 Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders Status COMPLETED Phase PHASE2
NCT00636155 EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status TERMINATED Phase PHASE2
NCT00632827 Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak) Status TERMINATED Phase PHASE2
NCT00630565 Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia Status TERMINATED Phase PHASE2/PHASE3